Cargando…

Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study

Introduction: Up to 73% of individuals with autism spectrum disorder (ASD) and intellectual disability (ID) currently have prescriptions for psychotropic drugs. This is explained by a higher prevalence of medical and psychiatric chronic comorbidities, which favors polypharmacy, increasing the probab...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Miguel, Laura, Ballester, Pura, Egoavil, Cecilia, Sánchez-Ocaña, María Luisa, García-Muñoz, Ana María, Cerdá, Begoña, Zafrilla, Pilar, Ramos, Enrique, Peiró, Ana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610471/ https://www.ncbi.nlm.nih.gov/pubmed/37895967 http://dx.doi.org/10.3390/ph16101496

Ejemplares similares

Antioxidant Activity in Extracts from Zingiberaceae Family: Cardamom, Turmeric, and Ginger
por: Ballester, Pura, et al.
Publicado: (2023)

Study of the Drivers of Inappropriate Use of Antibiotics in Community Pharmacy: Request for Antibiotics Without a Prescription, Degree of Adherence to Treatment and Correct Recycling of Leftover Treatment
por: Zarauz, José María, et al.
Publicado: (2022)

Self-Reported Medication Adherence Measured with Morisky Scales in Rare Disease Patients: A Systematic Review and Meta-Analysis
por: García-Muñoz, Ana María, et al.
Publicado: (2023)

Effect of Ginger on Inflammatory Diseases
por: Ballester, Pura, et al.
Publicado: (2022)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)

Positive perception of pharmacogenetic testing for psychotropic medications
por: Lanktree, Matthew B, et al.
Publicado: (2014)

CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis
por: Ballester, Pura, et al.
Publicado: (2023)

Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
por: Baldacci, Antoine, et al.
Publicado: (2023)

The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study
por: Ariefdjohan, Merlin, et al.
Publicado: (2021)

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC(®)) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
por: Blazy, Christopher, et al.
Publicado: (2022)

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy
por: Virgili Manrique, Anna C., et al.
Publicado: (2022)

Gender Trends in Psychotropic Medication Use in Autism
por: Huber, Christopher R, et al.
Publicado: (2022)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

Potential Role of Ginger (Zingiber officinale Roscoe) in the Prevention of Neurodegenerative Diseases
por: Arcusa, Raúl, et al.
Publicado: (2022)

Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences
por: Muriel, Javier, et al.
Publicado: (2023)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

Cardiac adverse reactions associated with psychotropic drugs
por: Girardin, François, et al.
Publicado: (2007)

Effects of a Fruit and Vegetable-Based Nutraceutical on Biomarkers of Inflammation and Oxidative Status in the Plasma of a Healthy Population: A Placebo-Controlled, Double-Blind, and Randomized Clinical Trial
por: Arcusa, Raúl, et al.
Publicado: (2021)

Pharmacogenetics Update on Biologic Therapy in Psoriasis
por: Muñoz-Aceituno, Ester, et al.
Publicado: (2020)

Psychotropic Medications Use among Children with Autism in Saudi Arabia
por: Alenezi, Shuliweeh, et al.
Publicado: (2022)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023)

Endothelial nitric oxide synthase gene polymorphisms and erectile dysfunction in chronic pain
por: Segura, Ana, et al.
Publicado: (2019)

Effect of Black Garlic Consumption on Endothelial Function and Lipid Profile: A Before-and-After Study in Hypercholesterolemic and Non-Hypercholesterolemic Subjects
por: Villaño, Débora, et al.
Publicado: (2023)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Arcusa, Raúl, et al.
Publicado: (2023)

Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders
por: Bose-Brill, Seuli, et al.
Publicado: (2017)

Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review
por: Sepúlveda-Lizcano, Lizeth, et al.
Publicado: (2023)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data
por: Hong, Minha, et al.
Publicado: (2017)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Pharmacogenetics for severe adverse drug reactions induced by molecular‐targeted therapy
por: Udagawa, Chihiro, et al.
Publicado: (2020)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Psychotropic drugs
por: Keltner, Norman L.
Publicado: (1993)

Glaucoma and Psychotropics
por: Cavaco, T., et al.
Publicado: (2022)

Neuropsychiatric profile and psychotropic medication use in adults with autism spectrum disorder: results from the Australian Longitudinal Study of Adults with Autism
por: Cvejic, Rachael C., et al.
Publicado: (2018)

Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK
por: Alfageh, Basmah H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vnrl68tjqphh2rgdskd7kfomka